RESEARCH
KRAS Mutation Subtypes May Influence Response to Neoadjuvant Therapy in Rectal CancerA meta-analysis investigated whether different KRAS mutation subtypes affect pathological complete response rates after neoadjuvant chemoradiotherapy in locally advanced rectal cancer. The study examined KRAS mutations within and outside exon 2. (BJS Open)